Link Pharma Chem Complete Financial Statements
In FYNone, Link Pharma Chem (LINKPH) reported revenue ₹26 Cr, net profit ₹-1 Cr and EPS ₹-1.40, with a net profit margin of -3.8% and ROE of -7.7%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see LINKPH stock live price.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
LINKPH Revenue, Net Profit & EBITDA — Year-on-Year Growth
LINKPH YoY (March 2025 vs Period).
LINKPH Income Statement — Revenue, EBITDA & Net Profit
Link Pharma Chem revenue ₹26 Cr, EBITDA ₹1 Cr, net profit ₹-1 Cr, EPS ₹-1.40 (None) — net profit margin -3.8%. Explore LINKPH investment value to estimate fundamental worth using multiple valuation models.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26 | 26 | 31 | 39 | 54 | 35 | 26 | 25 | 24 | 16 | 15 | 18 |
| Expenses | 25 | 25 | 31 | 36 | 50 | 32 | 23 | 23 | 21 | 14 | 13 | 18 |
| EBITDA | 1 | 0 | 0 | 3 | 4 | 3 | 3 | 2 | 3 | 2 | 3 | -1 |
| Operating Profit Margin % | 3.00% | 1.00% | -2.00% | 7.00% | 7.00% | 9.00% | 10.00% | 8.00% | 12.00% | 13.00% | -1.00% | -4.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -1 | -1 | -2 | 1 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | -3 |
| Tax | 0 | 0 | -1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | -1 |
| Net Profit | -1 | -1 | -1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | -2 |
| Earnings Per Share (₹) | -1.40 | -2.31 | -3.07 | 1.47 | 4.24 | 2.44 | 2.14 | 1.48 | 2.56 | 0.51 | 1.33 | -4.94 |
LINKPH Balance Sheet — Assets, Liabilities & Shareholders' Equity
LINKPH total assets ₹23 Cr, total equity ₹13 Cr, total liabilities ₹23 Cr (2025) — ROE -7.7%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 23 | 26 | 33 | 29 | 26 | 19 | 18 | 17 | 17 | 18 | 27 |
| Current Assets | 11 | 12 | 18 | 14 | 15 | 9 | 7 | 7 | 7 | 7 | 8 |
| Fixed Assets | 9 | 10 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 18 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 2 | 3 | 4 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 12 | 13 | 20 | 15 | 17 | 10 | 8 | 7 | 8 | 8 | 9 |
| LIABILITIES | |||||||||||
| Total Liabilities | 23 | 26 | 33 | 29 | 26 | 19 | 18 | 17 | 17 | 18 | 27 |
| Current Liabilities | 1 | 1 | 3 | 4 | 4 | 4 | 3 | 3 | 2 | 2 | 9 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 13 | 14 | 15 | 15 | 13 | 11 | 10 | 10 | 9 | 9 | 8 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 8 | 9 | 11 | 10 | 8 | 7 | 6 | 5 | 4 | 5 | 4 |
LINKPH Cash Flow Statement — Operating, Investing & Financing
Link Pharma Chem operating cash flow ₹3 Cr, investing ₹2 Cr, financing ₹-4 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | 0 | -2 | -1 | 5 | 3 | 1 | 4 | 2 | -4 | 5 |
| Investing Activities | 2 | 0 | 0 | -5 | -2 | -2 | -1 | -1 | -1 | 9 | -3 |
| Financing Activities | -4 | 0 | 2 | 2 | 0 | 1 | -1 | -3 | -2 | -6 | -1 |
| Net Cash Flow | 0 | 0 | 0 | -4 | 2 | 2 | 0 | 0 | 0 | -1 | 1 |